Press Releases
Information updates and press releases issued by Deep Genomics

Deep Genomics to Present at the 2023 Elevate Festival

September 20, 2023

Remarks will highlight the latest deep learning technology from Deep Genomics for 

discovering RNA disease mechanisms and candidate therapeutics


TORONTO--(BUSINESS WIRE)--September 20, 2023 Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that its ...

Deep Genomics Announces the Appointment of Brian O’Callaghan as CEO

September 15, 2023

O’Callaghan, a well-regarded life-science business leader with global experience and a significant track record of success, joins as part of plan to evolve Deep Genomics as a forward-integrated biopharmaceutical company 

Founder and current CEO Brendan Frey, Ph.D., F.R.S.C. to assume ...

Biotech Industry Leaders Join Deep Genomics Board of Directors and Scientific Advisory Board

January 6, 2023


TORONTO--(BUSINESS WIRE)--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, today announced additions to its Board of Directors and Scientific Advisory Board which will advance its capabilities to develop oligonucleotides designed to boost protein production across ...

Deep Genomics to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 6, 2022

TORONTO AND CAMBRIDGE, MA, January 6, 2022. Deep Genomics, the leading AI RNA therapeutics company, today announced that its Founder and CEO, Brendan Frey, PhD, FRSC, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 10 ...

Tal Zaks Joins Strategic Advisory Board at Deep Genomics

October 26, 2021


Former Moderna CMO and COVID-19 vaccine lead brings experience building hugely successful mRNA therapeutics company to Deep Genomics. 

TORONTO AND CAMBRIDGE, MA, October 26, 2021. Deep Genomics, the leading AI therapeutics company, welcomes Tal Zaks, M.D., Ph.D., to its Strategic Advisory Board, effective ...

Mila Announces Collaboration with Leading AI Therapeutics Company Deep Genomics

September 20, 2021

MONTREAL and TORONTO – September 20, 2021 – Mila, the Quebec Artificial Intelligence Institute, today announced the start of a partnership with Deep Genomics, a leading company in therapeutic artificial intelligence treatments. This collaboration will allow the company to join Mila's community and to take advantage ...

Deep Genomics Raises $180M in Series C Financing

July 28, 2021


-       Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic 

-       Oversubscribed round led by SoftBank Vision Fund 2, with CPP Investments, Fidelity Management & Research Company LLC, Alexandria Venture Investments, Amplitude Ventures, Khosla Ventures, Magnetic Ventures, and ...